GRI Bio Statistics

Total Valuation

GRI Bio has a market cap or net worth of $3.10 million. The enterprise value is -$74,601.

Market Cap	3.10M
Enterprise Value	-74,601

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025, before market open.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

GRI Bio has 2.35 million shares outstanding.

Current Share Class	2.35M
Shares Outstanding	2.35M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+7.02%
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	0.39%
Float	2.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.58
P/TBV Ratio	2.57
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.09.

Current Ratio	1.41
Quick Ratio	1.18
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -467.95% and return on invested capital (ROIC) is -275.36%.

Return on Equity (ROE)	-467.95%
Return on Assets (ROA)	-136.04%
Return on Invested Capital (ROIC)	-275.36%
Return on Capital Employed (ROCE)	-743.55%
Revenue Per Employee	n/a
Profits Per Employee	-$2.82M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -97.36% in the last 52 weeks. The beta is -2.11, so GRI Bio's price volatility has been lower than the market average.

Beta (5Y)	-2.11
52-Week Price Change	-97.36%
50-Day Moving Average	1.50
200-Day Moving Average	7.85
Relative Strength Index (RSI)	41.55
Average Volume (20 Days)	324,745

Short Selling Information

The latest short interest is 129,566, so 5.52% of the outstanding shares have been sold short.

Short Interest	129,566
Short Previous Month	65,311
Short % of Shares Out	5.52%
Short % of Float	5.52%
Short Ratio (days to cover)	0.31

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-9.39M
Pretax Income	-12.77M
Net Income	-11.28M
EBITDA	-9.39M
EBIT	-9.39M
Earnings Per Share (EPS)	-$36.38

Full Income Statement

Balance Sheet

The company has $3.28 million in cash and $108,000 in debt, giving a net cash position of $3.17 million or $1.35 per share.

Cash & Cash Equivalents	3.28M
Total Debt	108,000
Net Cash	3.17M
Net Cash Per Share	$1.35
Equity (Book Value)	1.21M
Book Value Per Share	2.29
Working Capital	1.15M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-8.14M
Capital Expenditures	n/a
Free Cash Flow	-8.14M
FCF Per Share	-$3.47

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GRI Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-363.96%
FCF Yield	-262.85%

Analyst Forecast

The average price target for GRI Bio is $22.00, which is 1,566.67% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$22.00
Price Target Difference	1,566.67%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-74.53%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on February 24, 2025. It was a reverse split with a ratio of 0.0588235:1.

Last Split Date	Feb 24, 2025
Split Type	Reverse
Split Ratio	0.0588235:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1